title: Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine.
authors.forename: Steven
authors.initials: S
authors.lastname: Rossi
authors.forename: Tony
authors.initials: T
authors.lastname: Yaksh
authors.forename: Heather
authors.initials: H
authors.lastname: Bentley
authors.forename: Geoffrey
authors.initials: G
authors.lastname: van den Brande
authors.forename: Igor
authors.initials: I
authors.lastname: Grant
authors.forename: Ronald
authors.initials: R
authors.lastname: Ellis
mesh_terms: D000480:Alkynes; D019380:Anti-HIV Agents / Q000652:urine*; D048588:Benzoxazines; D003429:Cross Reactions; D003521:Cyclopropanes; D013759:Dronabinol / Q000652:urine*; D005189:False Positive Reactions; D020719:Glucuronides / Q000652:urine*; D006213:Hallucinogens / Q000652:urine*; D006801:Humans; D007118:Immunoassay; D010078:Oxazines / Q000652:urine*; D015813:Substance Abuse Detection / Q000379:methods*
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D020719:Glucuronides; D006213:Hallucinogens; D010078:Oxazines; D013759:Dronabinol; C098320:efavirenz